DIMS vs. H.A.L.T. Technology: Clinical Evidence for Slowing Pediatric Myopia Progression
The Engineering Breakthrough: Dual-Zone Simultaneous Focus
A standard single-vision lens focuses central light rays onto the fovea, but due to the prolate (egg-shaped) geometry of the myopic eye, peripheral light rays focus behind the retina (Peripheral Hyperopic Defocus). This optical signal tricks the sclera into growing longer, accelerating axial elongation.
Myopia control lenses solve this with a dual-optical architecture:
- Central Clear Optical Zone (approx. 9mm to 11mm): Delivers crisp 6/6 distance vision through standard single-vision refractive correction.
- Peripheral Lenslet Treatment Ring (approx. 33mm): Embedded with hundreds of microscopic contiguous or concentric lenslets delivering of relative myopic defocus in front of the peripheral retina.
DIMS (MiYOSMART) vs. H.A.L.T. (Stellest): Metrology & Design
While both technologies aim to induce peripheral myopic defocus, their optical geometries differ fundamentally:
- DIMS Technology (Hoya MiYOSMART): Utilizes a honeycomb matrix of 396 identical spherical micro-lenslets, each measuring 1.03 mm in diameter with a constant power of .
- H.A.L.T. Technology (Essilor Stellest): Utilizes 1,021 contiguous aspherical lenslets arranged in 11 concentric rings. The power of the aspherical lenslets varies progressively, creating a 3D volumetric 'cushion of light' that slows elongation regardless of eye rotation angle.
Clinical Trial Evidence: 2-Year & 6-Year Longitudinal Data
In rigorous randomized controlled clinical trials:
Children wearing defocus lenses full-time () showed virtually zero abnormal axial elongation compared to age-matched controls wearing standard single-vision glasses.
Explore BluePro Sharp Focus 1.60 Ultra-Thin
Precision-engineered optical coatings featuring multi-layer dielectric anti-reflection, selective spectral absorption, and ±0.01D prescription tolerances.